Duffy Antigens and Malaria: The African Experience
Domain:
healthcareCreator:
Chi
Publisher:
Int
Host:
The Duffy blood group antigen is also known as Duffy Antigen Receptor for Chemokines (DARC) serves more functions than just a blood group antigen for serological reactions. It is a receptor for pro-inflammatory chemokines and Plasmodium vivax invasion of the red blood cells. A point mutation in the promoter region of the Duffy gene disrupts the binding of a transcription factor, leading to a lack of expression of the antigen on the erythrocytes. This Duffy negative phenotype is found predominantly in the African population. This mutation is advantageous as individuals with the Fy(a-b-) phenotype are less susceptible to P. vivax malaria. Malaria is caused by plasmodium parasites and it is endemic in Africa, where it is one of the leading causes of morbidity and mortality. It is believed that the absence of Duffy antigen in most Africans contributed to the resistance to P. vivax and by extension, reduced the burden of malaria in these endemic areas.
Similar
Common west African HLA antigens are associated with protection from severe malaria.Screening and identification of the dominant antigens of the African swine fever virusEnglish and the Pan-African Experience:Medical informatics in medical research - the Severe Malaria in African Children (SMAC) Network's experienceThe biology of unconventional invasion of Duffy-negative reticulocytes by Plasmodium vivax and its implication in malaria epidemiology and public healthAsymptomatic Malaria Infections in the Time of COVID-19 Pandemic: Experience from the Central African Republic